Omeicos Therapeutics collects 8.3 mln euros
Berlin-based Omeicos Therapeutics, which focuses on preventing and treating cardiovascular diseases, has raised 8.3 million euros in Series B financing. Vesalius Biocapital II S.A. SICAR and SMS Company Group led the round with participation from other investors that included KFW Group, VC Fonds Technologie Berlin and High-Tech Gründerfonds II GmbH & Co.
1 March 2017•1 min read
